Yves L Dory (Yves Dory)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Journal of medicinal chemistry

ChemMedChem

Chemistry (Weinheim an der Bergstrasse, Germany)

Scientific reports

Université de Sherbrooke Faculté des Sciences

University of Southampton (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Sherbrooke Faculté des Sciences

Canada

Full Professor :: Chemistry

Université de Sherbrooke Faculté des Sciences

Canada

Associate Professor :: Chemistry

Université de Sherbrooke Faculté des Sciences

Canada

Assistant Professor :: Chemistry

Endorecherche.inc

Canada

Group Leader :: Drug Discovery

Université de Sherbrooke Faculté des Sciences

Canada

PDF :: Chemistry

Education History

University of Southampton

United Kingdom

PHD :: Chemistry

Université de Rennes 1

France

MSC :: Chemistry

Publications

Pauline Navals, Anna Kwiatkowska, Nawel Mekdad, Frédéric Couture, Roxane Desjardins, Robert Day, Yves L Dory
Enhancing the Drug-Like Profile of a Potent Peptide PACE4 Inhibitor by the Formation of a Host-Guest Inclusion Complex with β-Cyclodextrin. Molecular pharmaceutics (2023)
Maxime Gagnon, Martin Savard, Thi Minh Hue Tran, Laurence Vincent, Alexandre Moquin, Philippe Tremblay, Xavier Roucou, Yves L Dory, Fernand Gobeil
Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease. Molecules (Basel, Switzerland) 28 (13) (2023)
Thomas Marmin, Yves L Dory
Self-Assembly of C3 Symmetric Rigid Macrolactams into Very Polar and Porous Trigonal Crystals. Chemistry (Weinheim an der Bergstrasse, Germany) 25 (27) (2019)
Anna Kwiatkowska, Frédéric Couture, Samia Ait-Mohand, Roxane Desjardins, Yves L Dory, Brigitte Guérin, Robert Day
Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug. Scientific reports 9 (1) (2019)
Jean-Louis Beaudeau, Véronique Blais, Brian J Holleran, Alexandre Bergeron, Graciela Piñeyro, Brigitte Guérin, Louis Gendron, Yves L Dory
N-Guanidyl and C-Tetrazole Leu-Enkephalin Derivatives: Efficient Mu and Delta Opioid Receptor Agonists with Improved Pharmacological Properties. ACS chemical neuroscience 10 (3) (2019)
Vahid Dianati, Anna Kwiatkowska, Frédéric Couture, Roxane Desjardins, Yves L Dory, Robert Day
Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines. Journal of medicinal chemistry 61 (18) (2018)
Vahid Dianati, Pauline Navals, Frédéric Couture, Roxane Desjardins, Anthony Dame, Anna Kwiatkowska, Robert Day, Yves L Dory
Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue. Journal of medicinal chemistry 61 (24) (2018)
Vahid Dianati, Azar Shamloo, Anna Kwiatkowska, Roxane Desjardins, Armand Soldera, Robert Day, Yves L Dory
Rational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3. ChemMedChem 12 (15) (2017)

Yves L Dory.css-eqlu8i{font-size:small;padding-left:4px;} (Yves Dory)

Publication Activity (10 Years)

Top Topics

Top Venues

Yves L Dory (Yves Dory)